Müllerian precursor lesions in serous ovarian cancer patients: Using the SEE-Fim and SEE-End protocol

Modern Pathology

Volumn 27, Issue 7, 2014, Pages 1002-1013

  Mingels, Marjanka J J M ^a   Van Ham, Maaike A P C ^a   De Kievit, Ineke M ^b   Snijders, Marc P M L ^b   Van Tilborg, Angela A G ^a   Bulten, Johan ^a   Massuger, Leon F A G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

atypical hyperplasia; endometrial intraepithelial carcinoma; ovarian neoplasms; serous carcinoma; serous tubal intraepithelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; COHORT ANALYSIS; ENDOMETRIAL ATYPICAL HYPERPLASIA; ENDOMETRIAL INTRAEPITHELIAL CARCINOMA; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; EPITHELIUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUELLERIAN DUCT; MULTICENTER STUDY; OBSERVATIONAL STUDY; OVARY CANCER; OVARY CARCINOMA; PREVALENCE; PRIORITY JOURNAL; PROCEDURES; SECTIONING AND EXTENSIVELY EXAMINING OF THE ENDOMETRIUM; SECTIONING AND EXTENSIVELY EXAMINING OF THE FIMBRIATED END; SEROUS TUBAL INTRAEPITHELIAL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX DYSPLASIA; UTERINE TUBE; CLINICAL TRIAL; CYSTADENOCARCINOMA; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PRECANCER; PROSPECTIVE STUDY; UTERINE TUBE TUMOR;

ADULT; AGED; CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULLERIAN DUCTS; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES;

EID: 84903780857     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.212     Document Type: Article

References (48)

1. van Altena AM, Karim-Kos HE, de Vries E, et al. Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands. Gynecol Oncol 2012;125: 649-654
2. Registration WNC. www.cijfersoverkanker.nl (IKNL; Integraal Kankercentrum Nederland), 2013
3. Gross AL, Kurman RJ, Vang R, et al. Precursor lesions of high-grade serous ovarian carcinoma: Morphological and molecular characteristics. J Oncol 2010;2010: 126295
4. Marquez RT, Baggerly KA, Patterson AP, et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 2005; 11: 6116-6126
5. Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol 2008;9: 1191-1197
6. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007;31: 161-169
7. Piek JM, van Diest PJ, Zweemer RP, et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001;195: 451-456
8. Przybycin CG, Kurman RJ, Ronnett BM, et al. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010;34: 1407-1416
9. Roh MH, Kindelberger D, Crum CP. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: Clues to serous tumor origin? Am J Surg Pathol 2009;33: 376-383
10. Tang S, Onuma K, Deb P, et al. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: A study of 300 consecutive cases. Int J Gynecol Pathol 2012;31: 103-110
11. Roelofsen T, van Kempen LC, van der Laak JA, et al. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: Can EIC be seen as the precursor lesion? Int J Gynecol Cancer 2012;22: 457-464
12. Bafghi A, Zafrani Y, Pautier P, et al. Endometrial disorders in patients with peritoneal serous papillary carcinoma. Eur J Obstet Gynecol Reprod Biol 2007;134: 101-104
13. Silverman BB, O'Neill RT, Mikuta JJ. Multiple malignant tumors associated with primary carcinoma of the ovary. Surg Gynecol Obstet 1972;134: 243-248
14. Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: A single institution review of 84 cases. Gynecol Oncol 2004;94: 456-462
15. van Altena AM, Geels YP, Bulten J, et al. Why do women with double primary carcinoma of the endometrium and ovary have a favorable prognosiš Int J Gynecol Pathol 2012;31: 344-351
16. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(Suppl 1): S161-S192
17. Lee KRTF, Tavassoli FA(eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press: Lyon, 2003
18. McCluggage WG. Benign diseases of the endometrium, In: Kurman RJ, Ellenson HL (eds). Blaustein's Pathology of the Female Genital Tract, 6th edn. Springer: New York, 2011, pp 305-358
19. Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006;30: 230-236
20. Mills AM, Longacre TA. Endometrial hyperplasia. Semin Diagn Pathol 2010;27: 199-214
21. Ambros RA, Sherman ME, Zahn CM, et al. Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995;26: 1260-1267
22. Mingels MJ, Roelofsen T, van der Laak JA, et al. Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls. Gynecol Oncol 2012;127: 88-93
23. Crum CP, Drapkin R, Miron A, et al. The distal fallopian tube: A new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 2007;19: 3-9
24. Piek JM, Verheijen RH, Kenemans P, et al. BRCA1/ 2-related ovarian cancers are of tubal origin: A hypothesis. Gynecol Oncol 2003;90: 491. (Pubitemid 36952054)
25. Mehrad M, Ning G, Chen EY, et al. A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol 2010;17: 293-302
26. Kommoss S, Schmidt D, Kommoss F, et al. Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: Consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol). Virchows Arch 2009;454: 249-256
27. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-Tier system. Am J Surg Pathol 2004;28: 496-504
28. Finch A, Beiner M, Lubinski J, et al. Salpingooophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006;296: 185-192
29. Bonnar J, Kraszewski A, Davis WB. Incidental pathology at vaginal hysterectomy for genital prolapse. J Obstet Gynaecol Br Commonw 1970;77: 1137-1139
30. Frick AC, Walters MD, Larkin KS, Barber MD. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol 2010;202: 507-4
31. Mahajan G, Kotru M, Batra M, et al. Usefulness of histopathological examination in uterine prolapse specimens. Aust NZ J Obstet Gynaecol 2011;51: 403-405
32. Mingels MJ, Geels PG, Pijnenborg JM, et al. Histopathologic assessment of the entire endometrium in asymptomatic women. Human Pathol 2013;44: 2293-2301
33. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: A descriptive classification. Int J Gynecol Pathol 2008;27: 1-9
34. Bunting MW, Jaaback KS, McNally OM. Routine hysterectomy in the surgical management of ovarian cancer: A retrospective case series, physician opinion survey, and review of the literature. Int J Gynecol Cancer 2011;21: 1579-1584
35. Kurman RJ, McConnell TG. Precursors of endometrial and ovarian carcinoma. Virchows Arch 2010;456: 1-12
36. Jongen VH, Sluijmer AV, Heineman MJ. The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer. Maturitas 2002;43: 77-85
37. Poels LG, Jap PH, Ramaekers FF, et al. Characterization of a hormone-producing ovarian carcinoma cell line. Gynecol Oncol 1989;32: 203-214
38. Ridderheim M, Mahlck CG, Selstam G, et al. Steroid production in different parts of malignant and benign ovarian tumors in vitro. Cancer Res 1993;53: 2309-2312
39. Baergen RN, Warren CD, Isacson C, et al. Early uterine serous carcinoma: Clonal origin of extrauterine disease. Int J Gynecol Pathol 2001;20: 214-219
40. Jarboe EA, Miron A, Carlson JW, et al. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: Frequency and potential significance. Int J Gynecol Pathol 2009;28: 308-315
41. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol 2000;24: 726-732
42. Zheng W, Schwartz PE. Serous EIC as an early form of uterine papillary serous carcinoma: Recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol 2005;96: 579-582
43. Massuger L, Roelofsen T, Ham M, et al. The origin of serous ovarian cancer may be found in the uterus: A novel hypothesis. Med Hypotheses 2010;74: 859-861
44. Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am J Surg Pathol 2010;34: 433-443
45. Seidman JD, Zhao P, Yemelyanova A. Primary peritoneal high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol 2011;120: 470-473
46. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6: 963-968
47. Buller RE, Skilling JS, Sood AK, et al. Field cancerization: Why late recurrent ovarian cancer is not recurrent. Am J Obstet Gynecol 1998;178: 641-649
48. Damania D, Roy HK, Kunte D, et al. Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells. Int J Cancer 2013;133: 1143-1152